tiprankstipranks
Advertisement
Advertisement

AU:ARX Stock Latest News

Aroa Biosurgery Lodges Appendix 4G, Reaffirming ASX Governance Compliance
Company AnnouncementsAroa Biosurgery Lodges Appendix 4G, Reaffirming ASX Governance Compliance
2d ago
ARX
Aroa Biosurgery Sets Out 2026 Performance and Key Dates in Annual Report
PremiumCompany Announcements
Aroa Biosurgery Sets Out 2026 Performance and Key Dates in Annual Report
2d ago
ARX
Aroa Biosurgery director trims indirect shareholding in on-market sale
PremiumCompany Announcements
Aroa Biosurgery director trims indirect shareholding in on-market sale
3d ago
ARX
Aroa Biosurgery Sets AGM Date as Long-Serving Director Plans Retirement
PremiumCompany Announcements
Aroa Biosurgery Sets AGM Date as Long-Serving Director Plans Retirement
8d ago
ARX
Aroa Biosurgery Corrects Typo in FY26 Results Investor Presentation
PremiumCompany Announcements
Aroa Biosurgery Corrects Typo in FY26 Results Investor Presentation
1M ago
ARX
Aroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment
PremiumCompany AnnouncementsAroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment
1M ago
ARX
Aroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift
Premium
Company Announcements
Aroa Biosurgery Beats FY26 Guidance on Strong Myriad Sales and Margin Lift
2M ago
ARX
Aroa Biosurgery Seeks ASX Quotation for New Share Issue
Premium
Company Announcements
Aroa Biosurgery Seeks ASX Quotation for New Share Issue
3M ago
ARX
Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution
PremiumCompany Announcements
Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution
3M ago
ARX
Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers
PremiumCompany Announcements
Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers
3M ago
ARX
Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares
PremiumCompany Announcements
Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares
3M ago
ARX
Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial
PremiumCompany Announcements
Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial
5M ago
ARX
Aroa Biosurgery Seeks ASX Quotation for New Shares Issued Under Employee Incentive Scheme
PremiumCompany AnnouncementsAroa Biosurgery Seeks ASX Quotation for New Shares Issued Under Employee Incentive Scheme
5M ago
ARX
Aroa Biosurgery Issues Investor-Focused February 2026 Business Update
Premium
Company Announcements
Aroa Biosurgery Issues Investor-Focused February 2026 Business Update
5M ago
ARX
Aroa Biosurgery Poised to Gain From US Reimbursement Shift as New Data Backs Myriad
Premium
Company Announcements
Aroa Biosurgery Poised to Gain From US Reimbursement Shift as New Data Backs Myriad
5M ago
ARX
Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX
PremiumCompany Announcements
Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX
5M ago
ARX
Aroa Biosurgery Schedules Investor Webinar to Detail Symphony Reimbursement and Clinical Data
PremiumCompany Announcements
Aroa Biosurgery Schedules Investor Webinar to Detail Symphony Reimbursement and Clinical Data
5M ago
ARX
Aroa Biosurgery Study Backs Efficacy and Cost Edge of Myriad Trauma Scaffold
PremiumCompany Announcements
Aroa Biosurgery Study Backs Efficacy and Cost Edge of Myriad Trauma Scaffold
5M ago
ARX
Aroa Biosurgery Options Lapse Following Unmet Vesting Conditions
PremiumCompany Announcements
Aroa Biosurgery Options Lapse Following Unmet Vesting Conditions
6M ago
ARX
Aroa’s Symphony Wins Extended US Medicare Access as CMS Tightens Skin Substitute Rules
PremiumCompany AnnouncementsAroa’s Symphony Wins Extended US Medicare Access as CMS Tightens Skin Substitute Rules
7M ago
ARX
Aroa Biosurgery Ltd Reports Half-Year 2026 Results
Premium
Company Announcements
Aroa Biosurgery Ltd Reports Half-Year 2026 Results
7M ago
ARX
Aroa Biosurgery Achieves Strong Revenue Growth and Financial Stability in H1 FY26
Premium
Company Announcements
Aroa Biosurgery Achieves Strong Revenue Growth and Financial Stability in H1 FY26
7M ago
ARX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >